anti-4-Hydroxy-2-hexenal [4-HHE], mAb (HHE53)
Code | Size | Price |
---|
JAI-MHH-030N-30ug | 30 ug | £971.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: Mouse IgG1kappa
Antibody Clonality: Monoclonal
Antibody Clone: HHE53
Regulatory Status: RUO
Target Species: Human
Application: Immunohistochemistry (IHC)
Shipping:
BLUE ICE
Storage:
-20°C
Documents
Further Information
EClass:
32160000
Form (Short):
liquid
Formulation:
Frozen liquid. Contains 10mM PBS, 0.1% NaN3 and 0.5% BSA.
Handling Advice:
Avoid freeze/thaw cycles.
Immunogen:
HHE-modified keyhole-lympet hemocyanine.
Long Description:
Monoclonal Antibody. Recognizes HHE-modified proteins (especially HHE-His Michael adducts). Frozen liquid. Contains 10mM PBS, 0.1% NaN3 and 0.5% BSA. 4-hydroxy-2-alkenal is one of the major lipid peroxidation products, and shows many biological effects such as high toxicity to cells. Among them, 4-hydroxy-2-hexenal (HHE) is an aldehyde formed during peroxidation of n-3 fatty acids such as docosahexaenoic acid. HHE is highly reactive aldehyde and reacts with histidine residue of protein to form Michael-addition type adducts.
Package Type:
Plastic Vial
Product Description:
4-hydroxy-2-alkenal is one of the major lipid peroxidation products, and shows many biological effects such as high toxicity to cells. Among them, 4-hydroxy-2-hexenal (HHE) is an aldehyde formed during peroxidation of n-3 fatty acids such as docosahexaenoic acid. HHE is highly reactive aldehyde and reacts with histidine residue of protein to form Michael-addition type adducts.
Source / Host:
Ascites
Specificity:
Recognizes HHE-modified proteins (especially HHE-His Michael adducts).
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibodies
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 3 years after receipt when stored at -20°C.
References
Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids: S. Yamada, et al.; J. Lipid. Res. 45, 626 (2004) | Accumulation of protein-bound 4-hydroxy-2-hexenal in spinal cords from patients with sporadic amyotrophic lateralsclerosis: N. Shibata, et al.; Brain Res. 1019, 170 (2004)
Related Products
Product Name | Product Code | Supplier | anti-Acrolein [ACR], mAb (5F6) | JAI-MAR-020N | JaICA | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
anti-Acrolein [ACR], mAb (5F6) | JAI-MAR-100N | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-Dibromo-tyrosine [DiBrY], mAb (3A5) | JAI-MBY-020P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-Crotonaldehyde [CRA], mAb (82D3) | JAI-MCA-030N | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-Dityrosine [DT], mAb (1C3) | JAI-MDT-020P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-Hexanoyl-Lys [HEL], mAb (5F12) | JAI-MHL-021P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||